Cite
HARVARD Citation
Ryan, C. et al. (n.d.). Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Lancet oncology. 16 (2), pp. 152-160. [Online].